174 related articles for article (PubMed ID: 7936652)
41. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes.
Stacey DW; Roudebush M; Day R; Mosser SD; Gibbs JB; Feig LA
Oncogene; 1991 Dec; 6(12):2297-304. PubMed ID: 1766676
[TBL] [Abstract][Full Text] [Related]
42. R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism.
Wang HG; Millan JA; Cox AD; Der CJ; Rapp UR; Beck T; Zha H; Reed JC
J Cell Biol; 1995 May; 129(4):1103-14. PubMed ID: 7744959
[TBL] [Abstract][Full Text] [Related]
43. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
[TBL] [Abstract][Full Text] [Related]
44. Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.
Yanagihara K; Ciardiello F; Talbot N; McGeady ML; Cooper H; Benade L; Salomon DS; Bassin RH
Oncogene; 1990 Aug; 5(8):1179-86. PubMed ID: 2202950
[TBL] [Abstract][Full Text] [Related]
45. TC21 causes transformation by Raf-independent signaling pathways.
Graham SM; Vojtek AB; Huff SY; Cox AD; Clark GJ; Cooper JA; Der CJ
Mol Cell Biol; 1996 Nov; 16(11):6132-40. PubMed ID: 8887643
[TBL] [Abstract][Full Text] [Related]
46. Differential roles of Akt, Rac, and Ral in R-Ras-mediated cellular transformation, adhesion, and survival.
Osada M; Tolkacheva T; Li W; Chan TO; Tsichlis PN; Saez R; Kimmelman AC; Chan AM
Mol Cell Biol; 1999 Sep; 19(9):6333-44. PubMed ID: 10454580
[TBL] [Abstract][Full Text] [Related]
47. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM
Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065
[TBL] [Abstract][Full Text] [Related]
48. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation.
Khosravi-Far R; Solski PA; Clark GJ; Kinch MS; Der CJ
Mol Cell Biol; 1995 Nov; 15(11):6443-53. PubMed ID: 7565796
[TBL] [Abstract][Full Text] [Related]
49. Stage-specific transformation of murine B lineage cells by ras and myc.
Overell RW; Weisser KE; Hess B; Namen AE; Grabstein KH
Oncogene; 1989 Dec; 4(12):1425-32. PubMed ID: 2687765
[TBL] [Abstract][Full Text] [Related]
50. Correlation between H-ras p21TLeu61 protein content and tumorigenicity of NIH3T3 cells.
Bizub D; Blair D; Alvord G; Skalka AM
Oncogene; 1988 Oct; 3(4):443-8. PubMed ID: 3078952
[TBL] [Abstract][Full Text] [Related]
51. Mutant but not normal p21 ras elevates inositol phospholipid breakdown in two different cell systems.
Hancock JF; Marshall CJ; McKay IA; Gardner S; Houslay MD; Hall A; Wakelam MJ
Oncogene; 1988 Aug; 3(2):187-93. PubMed ID: 2842715
[TBL] [Abstract][Full Text] [Related]
52. Mas oncogene signaling and transformation require the small GTP-binding protein Rac.
Zohn IE; Symons M; Chrzanowska-Wodnicka M; Westwick JK; Der CJ
Mol Cell Biol; 1998 Mar; 18(3):1225-35. PubMed ID: 9488437
[TBL] [Abstract][Full Text] [Related]
53. Induction of apoptosis in NIH3T3 cells after serum deprivation by overexpression of rho-p21, a GTPase protein of the ras superfamily.
Jiménez B; Arends M; Esteve P; Perona R; Sánchez R; Ramón y Cajal S; Wyllie A; Lacal JC
Oncogene; 1995 Mar; 10(5):811-6. PubMed ID: 7898922
[TBL] [Abstract][Full Text] [Related]
54. ras proteins: biological effects and biochemical targets (review).
Bar-Sagi D
Anticancer Res; 1989; 9(5):1427-37. PubMed ID: 2686537
[TBL] [Abstract][Full Text] [Related]
55. A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.
Bentley C; Jurinka SS; Kljavin NM; Vartanian S; Ramani SR; Gonzalez LC; Yu K; Modrusan Z; Du P; Bourgon R; Neve RM; Stokoe D
Biochem J; 2013 Jun; 452(2):313-20. PubMed ID: 23496764
[TBL] [Abstract][Full Text] [Related]
56. M-Ras/R-Ras3, a transforming ras protein regulated by Sos1, GRF1, and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6.
Quilliam LA; Castro AF; Rogers-Graham KS; Martin CB; Der CJ; Bi C
J Biol Chem; 1999 Aug; 274(34):23850-7. PubMed ID: 10446149
[TBL] [Abstract][Full Text] [Related]
57. Experimental metastatic ability of H-ras-transformed NIH3T3 cells.
Bondy GP; Wilson S; Chambers AF
Cancer Res; 1985 Dec; 45(12 Pt 1):6005-9. PubMed ID: 4063960
[TBL] [Abstract][Full Text] [Related]
58. Protein kinase B/akt and rab5 mediate Ras activation of endocytosis.
Barbieri MA; Kohn AD; Roth RA; Stahl PD
J Biol Chem; 1998 Jul; 273(31):19367-70. PubMed ID: 9677351
[TBL] [Abstract][Full Text] [Related]
59. R-Ras controls membrane protrusion and cell migration through the spatial regulation of Rac and Rho.
Wozniak MA; Kwong L; Chodniewicz D; Klemke RL; Keely PJ
Mol Biol Cell; 2005 Jan; 16(1):84-96. PubMed ID: 15525681
[TBL] [Abstract][Full Text] [Related]
60. Transformation with oncogenic Ras and the simian virus 40 T antigens induces caspase-dependent sensitivity to fatty acid biosynthetic inhibition.
Xu S; Spencer CM; Munger J
J Virol; 2015 Jun; 89(12):6406-17. PubMed ID: 25855740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
